Life Sciences compliance news

UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.

Advanced Clinical, a leading provider of clinical research services, today announced the appointment of Rosemarie Truman as Executive Vice President of Solutions.

Advanced Life Sciences CEO Michael Flavin decided a pair of superiority trials was the best way to prove the efficacy of the company’s Restanza in community-acquired bacterial pneumonia, given the "stalemate" at FDA regarding the use of non-inferiority trials in antibiotics.

September 02, 2010 -- What if you could walk into the pharmacy and get a self diagnostic test for conditions that currently require clinical laboratory testing? Or what if you could get a an instant test result at your GP’s surgery for cardiac disease or breast cancer - without needing to wait for t...

BUFFALO, N.Y. -- Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept. 11 on "T...

MyD88 and Toll/IL-1R domain-containing adaptor protein (TIRAP)are required for the TLR4 response to LPS stimulation in mammals,but the functions of the two adaptors and their involvementin zebrafish insensitivity to LPS remains unknown. We presenta functional analysis of zebrafish Myd88 and Tirap an...

Glasgow, Scotland, 2 September 2010 Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface Enhanced Raman Spectroscopy (SERS) and Surface Enhanced Resonance Raman Scattering (SERRS) for clinical research and molecular diagnostics...

New York, NY – August 27, 2010 – Global life sciences industry’s spending on technology, especially from pharma and biotech companies, is projected to grow over the next five years, according to Ovum. Emerging markets, particularly China, India, and Brazil will join North American markets in becomin...

Paris, France; Chennai, India – August 10, 2010 – As part of the Cegedim Dendrite Alliance Program, created to expand its open business model through alliances with leading technology, software and consulting companies, Cegedim Dendrite today announced its partnership in India with TAKE Solutions Lt...

2 September 2010: Australian public companies are increasingly attracting international investment from US and European companies through creative methods of financing, says Australia’s biotechnology industry organisation, AusBiotech. The global financial crisis has seen more Australian biotechnolog...